Press release
27.01.2023 To the attention of interested persons Review of sickle cell disease medicine Adakveo started download document …
Press release
27.01.2023 To the attention of interested persons EMA confirms measures to minimise risk of serious side effects with Janus kinase […]
Press release
13.01.2023 To the attention of interested persons Withdrawal of marketing authorisations for amfepramone medicines within the EU. download document …
Press release
13.01.2023 To the attention of interested persons Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 9 – 12 January […]
Important notification
13.01.2023 For the attention of healthcare professionals and researchers in healthcare institutions who intend to design, manufacture, modify and use […]
Important notification
23.12.2022 To the attention of manufacturers, authorised representatives, economic operators and all stakeholders Please be informed that on 9 December […]
Press release
16.12.2022 To the attention of interested persons EMA recommends withdrawal of pholcodine medicines from EU market download document …
Important notification
13.12.2022 To the attention of manufacturers, authorised representatives, economic operators and all stakeholders Please be informed that Order no. 3539 […]
Important notification
12.12.2022 To the attention of manufacturers of medical devices, in vitro diagnostic medical devices and all stakeholders Please be informed […]
Press release
06.12.2022 To the attention of interested persons ETF concludes that bivalent original/Omicron BA.4-5 mRNA vaccines may be used for primary […]